Document is current
Any future updates will be listed below
-
Authors
Zhou, Royce W.
Parsons, Ramon E.
-
Funding
Funding for this research was provided by:
Royce Zhou (F30CA243207)
Ramon Parsons (R35CA220491)
- License Information
-
More Information
Article History
Received: 4 April 2023
Accepted: 10 June 2023
First Online: 6 July 2023
Declarations
:
: Not applicable.
: Not applicable.
: R.E.P. owns equity in Therapten. R.E.P. reports other activities with Columbia University and Regeneron Pharmaceuticals. The other authors report no financial disclosures or conflicts of interest.
